Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes

Adv Cancer Res. 2018:138:99-142. doi: 10.1016/bs.acr.2018.02.004. Epub 2018 Mar 2.

Abstract

The extracellular-regulated kinases ERK1 and ERK2 are evolutionarily conserved, ubiquitous serine-threonine kinases that are involved in regulating cellular signaling in both normal and pathological conditions. Their expression is critical for development and their hyperactivation is a major factor in cancer development and progression. Since their discovery as one of the major signaling mediators activated by mitogens and Ras mutation, we have learned much about their regulation, including their activation, binding partners and substrates. In this review I will discuss some of what has been discovered about the members of the Ras to ERK pathway, including regulation of their activation by growth factors and cell adhesion pathways. Looking downstream of ERK activation I will also highlight some of the many ERK substrates that have been discovered, including those involved in feedback regulation, cell migration and cell cycle progression through the control of transcription, pre-mRNA splicing and protein synthesis.

Keywords: Adhesion; ERK; Feedback; MEK; Proliferation; RAS; Raf; Signaling; Substrates.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Cell Adhesion / drug effects*
  • Humans
  • MAP Kinase Signaling System / drug effects*
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Neoplasms / pathology*
  • Signal Transduction / drug effects*
  • ras Proteins / metabolism*

Substances

  • Antineoplastic Agents
  • ras Proteins